PCIG
ELV icon

Partners Capital Investment Group’s Elevance Health ELV Stock Holding History

Partners Capital Investment Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,928
Closed -$9.11M – 276
2023
Q3 		$9.11M Sell
20,928
-726
-3% -$329K 0.22% 74
2023
Q2 		$9.62M Sell
21,654
-2,346
-10% -$1.08M 0.21% 80
2023
Q1 		$11M Sell
24,000
-2,083
-8% -$991K 0.47% 45
2022
Q4 		$13.4M Buy
26,083
+23,185
+800% +$11.8M 0.64% 37
2022
Q3 		$1.32M Buy
+2,898
New +$1.39M 0.08% 97
2020
Q4 		– Sell
-875
Closed -$235K – 122
2020
Q3 		$235K Sell
875
-3,556
-80% -$957K 0.01% 107
2020
Q2 		$1.17M Sell
4,431
-32,368
-88% -$8.64M 0.06% 83
2020
Q1 		$8.36M Buy
36,799
+2,613
+8% +$712K 0.57% 44
2019
Q4 		$10.3M Buy
34,186
+971
+3% +$267K 0.78% 37
2019
Q3 		$7.97M Buy
33,215
+9,298
+39% +$2.55M 0.69% 45
2019
Q2 		$6.75M Buy
23,917
+2,352
+11% +$642K 0.67% 48
2019
Q1 		$6.19M Buy
+21,565
New +$6.24M 0.61% 44

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Partners Capital Investment Group's ELV Position: Q4 2023 in Review

Partners Capital Investment Group sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 20,928 shares — an estimated $9.11M sold.

Partners Capital Investment Group first reported a position in ELV in Q1 2019 and held it in 12 quarters. The position peaked at $13.4M in Q4 2022. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Partners Capital Investment Group reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Partners Capital Investment Group sold 20,928 Elevance Health shares in Q4 2023, an estimated $9.11M.
  • Partners Capital Investment Group first reported a position in Elevance Health in Q1 2019 and held it in 12 quarters.
  • Partners Capital Investment Group's Elevance Health position peaked at $13.4M in Q4 2022.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Partners Capital Investment Group's 13F filing for Q4 2023, filed 12 Feb 2024.